Fatimat Kipkeeva

Ms. Fatimat Kipkeeva

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
FKFatimat Kipkeeva
Fatimat Kipkeeva
TMTatyana Muzaffarova
Tatyana Muzaffarova
AKAlexandra Korotaeva
Alexandra Korotaeva
MNMaxim Petrovich Nikulin
Maxim Petrovich Nikulin
KMKristina Mikhalchuk
Kristina Mikhalchuk
AKAlexander Karpukhin
Alexander Karpukhin
Gastric cancer (GC) is one of the most common and difficult diseases to treat. The study of signaling pathway regulation by microRNA provides information on the mechanisms of GC development and is the basis for biomarker creation. In this study, a circuit of microRNA interactions with signaling pathways was constructed. The microRNAs, associated with metastasis and chemoresistance, are described. In most cases, microRNAs in GC regulate the Wnt/β-catenin, PI3K/AKT/mTOR, RAS/RAF/ERK/MAPK, NF-kB, TGF-β, and JAK/STAT pathways. Part of the microRNA acts on several target genes that function in different pathways. This often leads to an intensification of the induced processes. MicroRNAs have also been described that have the opposite effect on different pathways, causing different functional consequences. By acting on several target genes, or genes associated with several pathways, microRNAs can function in a signaling network. MicroRNAs associated with metastasis most often interact with the Wnt/β-catenin pathway. MicroRNAs affecting chemoresistance, in most cases, affect the regulators of apoptosis and are associated with the PI3K/AKT/mTOR pathway. The characteristics of microRNAs proposed as candidates for GC biomarkers were analyzed. The currently developed diagnostic and prognostic panels of microRNAs are also considered.

1 May 2020 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
FKFatimat Kipkeeva
Fatimat Kipkeeva
ТMТ. А. Muzaffarova
Т. А. Muzaffarova
MNM. P. Nikulin
M. P. Nikulin
PAP. V. Apanovich
P. V. Apanovich
MNM. N. Narimanov
M. N. Narimanov
AKA. V. Karpukhin
A. V. Karpukhin

18 July 2019 in Bulletin of Russian State Medical University
Verified
Journal Article
Open access
TMT.A. Muzaffarova
T.A. Muzaffarova
ONO.V. Novikova
O.V. Novikova
ISI.Yu. Sachkov
I.Yu. Sachkov
FKFatimat Kipkeeva
Fatimat Kipkeeva
EGE.K. Ginter
E.K. Ginter
AKA.V. Karpukhin
A.V. Karpukhin
Desmoid-type fibromatosis (DF) is a rare mesenchymal tumor occurring in only 2 to 4 people per 1,000,000 population a year. Desmoid tumors are either seen sporadically or in individuals with familial adenomatous polyposis (FAP). The etiology of sporadic DF is uncertain. The aim of this study was to estimate the potential significance of germline mutations in the APC gene in patients with sporadic DF. APC exons were amplified, studied using conformation sensitive gel electrophoresis and then Sanger-sequenced. The obtained data were processed in Statistica 10. Mutations were detected in 6 (12%) of 51 participants with sporadic DF. Those 6 patients shared a typical DF phenotype characterized by early age of onset (5.8 years on average, in contrast to the patients without APC mutations, who developed DF at 19 years of age; p = 0.02), severe clinical course, multifocal localization on the trunk, and poor prognosis. All of the detected APC mutations were localized to the 3'-end of the gene. For the purpose of comparison, we analyzed a sample of 12 patients with FAP-associated DF. Of those patients, 6 carried mutations in the APC gene. In the analyzed sample, the patients with FAP and the mutant APC gene developed DF at older age (35 years) than the patients with sporadic DF (p = 0.004) and their tumors were not multifocal. This means that sporadic and FAP-associated desmoids have different phenotypes in patients with APC mutations. Patients with sporadic tumors have mutations at the 3'-end of the APC gene more often than individuals with FAP-associated DF. To our knowledge, this is the first study to characterize the subtype of sporadic desmoid fibromatosis phenotypically determined by germline mutations in the APC gene.

11 December 2018 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
FKFatimat Kipkeeva
Fatimat Kipkeeva
ТMТ. А. Muzaffarova
Т. А. Muzaffarova
MNMaxim Petrovich Nikulin
Maxim Petrovich Nikulin
PAP. V. Apanovich
P. V. Apanovich
SNS. N. Nered
S. N. Nered
AKAlexander Karpukhin
Alexander Karpukhin
Objective of the study. Identification of genes, the expression of which is associated with the metastasis of gastric cancer tumor.Materials and methods. Quantitative real-time PCR on paired tumor – normal samples.Results. An association with the metastasis of the VEGFR1, FGFR2 and NRP-1 gene expression is shown. The odds ratio (OR) was the highest for the FGFR2 gene: OR 175.00; 95 % CI 8.972–3413.271; for the VEGFR1 gene, OR 4.622, 95 % CI 1.240–17.227, for NRP1 – OR 2.667; 95 % CI 0.597–11.915. When assessing the jointly elevated expression of VEGFR1 and NRP1 genes, OR 5,778; 95 % CI 1.393–23.909; p = 0.0147. The frequency of increased expression of FGFR2 was 5 % in case of metastasis, while in the case of localized GC it reached 53 %.Conclusion. The target drug against FGFR2, which is being developed, is likely to have a limited 5–10 % frequency of effective action in metastatic GC. Its use in the early stages of GC can help prevent the transition of the tumor to the metastatic stage. The possible interact tion of VEGFR1 and NRP1 will result in a small contribution to the metastasis of GC as compared to the effect of VEGFR1-only expression.

6 May 2024 in Voprosy onkologii
Verified
Journal Article
Open access
FKFatimat Kipkeeva
Fatimat Kipkeeva
DMDanzan Mansorunov
Danzan Mansorunov
ТМТатьяна Александровна Музаффарова
Татьяна Александровна Музаффарова
NANatalya Apanovich
Natalya Apanovich
MNMaxim Petrovich Nikulin
Maxim Petrovich Nikulin
AAAndrei Alimov
Andrei Alimov
Currently, immune checkpoints inhibitors (ICIs) are widely used in clinical practice. However, for a significant group of patients, monotherapy with an ICI is not effective. One of the reasons for this lies in the complex mechanism of interaction between receptors and ligands of different ICs, which are simultaneously present on the cell surface. Simultaneous inhibition of various ICs is considered as one of possible solutions to this problem. Clinical trials of ICI combinations are currently underway. Some of these combinations are approved for use in clinical practice. The signaling pathways associated with ICs are being actively studied. Targeting of these pathways together with ICIs is a new therapy strategy. This review summarizes data on PD-1/PD-L1 and TIM-3/Gal-9 immune checkpoints as a promising targets of ICI combination. The signaling pathways associated with the molecules of these ICs have also been characterized. The prospect of therapies based on simultaneous blocking of PD-1, PD-L1, TIM-3, Gal-9 molecules and their signalling pathways were evaluated. В настоящее время широкое распространение в клинической практике получили препараты, нацеленные на ингибирование иммунных контрольных точек (ИКТ). Однако для значительной группы больных монотерапия ингибитором ИКТ не является эффективной. Одна из причин этого кроется в сложном механизме взаимодействия между рядом белков, являющихся рецепторами и лигандами разных ИКТ, которые одновременно присутствуют на поверхности клетки. Одно из решений этой проблемы — совместное подавление экспрессии нескольких молекул ИКТ. В настоящее время проходят клинические исследования, в которых тестируются комбинации ингибиторов ИКТ. Некоторые из таких комбинаций одобрены для использования в клинической практике. Также в последнее время активно изучаются сигнальные пути, вовлеченные в формирование иммунного ответа в результате трансдукции сигнала через белки ИКТ. Таргетное воздействие на ключевые молекулы этих путей совместно с ингибированием контрольных точек рассматривается в качестве новой стратегии иммунотерапии. В обзоре рассмотрены перспективные мишени иммунотаргетной терапии — PD-1/PD-L1 и TIM-3/Gal-9. Охарактеризованы сигнальные пути, ассоциированные с молекулами этих ИКТ. Проведена оценка потенциальных подходов, основанных на одновременном воздействии на молекулы PD-1, PD-L1, TIM-3, Gal-9 и их сигнальные пути.

6 September 2026 in Вестник психофизиологии
Verified
Journal Article
Closed access
ЕШЕ.н. Шабалина
Е.н. Шабалина
НШН.ю. Шабалин
Н.ю. Шабалин
СКС.в. Костюк
С.в. Костюк
НВН.н. Вейко
Н.н. Вейко
ТМТ.а. Музаффарова
Т.а. Музаффарова
PUPavel Umriukhin
Pavel Umriukhin
Данное исследование посвящено комплексному изучению нейробиологических факторов, определяющих индивидуальные различия в процессах когнитивного старения. Работа сфокусирована на анализе взаимосвязей между базальным уровнем кортикостерона, индивидуально-типологическими особенностями поведения (тревожностью) и экспрессией гена синапсина I (syn1) в структурах головного мозга крыс. Эксперимент выполнен на 48 крысах-самцах линии Wistar, разделенных на две возрастные группы: молодые (6–8 мес., n=21) и старые (18–24 мес., n=27). Методологический подход включал оценку уровня тревожности в тесте «открытое поле» и анализ пространственной памяти в водном лабиринте Морриса и лабиринте Барнс. Содержание кортикостерона в плазме определяли методом ИФА, а уровень экспрессии гена syn1 в структурах мозга анализировали с помощью количественной ПЦР в реальном времени. В ходе работы установлено, что старение сопровождается значимым ростом базального уровня кортикостерона и снижением эффективности пространственного обучения. Одним из ключевых результатов исследования стало обнаружение возрастной инверсии связи между уровнем тревожности и экспрессией гена syn1 в вентральном гиппокампе: если у молодых животных высокая экспрессия syn1 в вентральном гиппокампе ассоциирована с низкотревожным фенотипом, то в старшей возрастной группе повышенный уровень экспрессии данного гена характерен для высокотревожных особей. Это указывает на глубокую функциональную перестройку лимбической системы в процессе онтогенеза. Показано, что влияние тревожности на когнитивную продуктивность проявляется преимущественно в старшем возрасте и зависит от интенсивности стрессорного контекста задачи. Высокая тревожность у старых крыс коррелирует с ухудшением результатов в условиях водного лабиринта Морриса (высокий стресс), но способствует успешному обучению в лабиринте Барнс (умеренный стресс). Полученные данные расширяют представления о механизмах гетерогенности старения мозга. Выявленные закономерности расширяют представления о механизмах когнитивного старения, что может быть полезно при разработке стратегий профилактики когнитивных нарушений в пожилом возрасте. This study investigates the neurobiological factors underlying individual differences in cognitive aging. The research focuses on the interrelationships between basal corticosterone levels, individual-typological behavioral traits (anxiety), and the expression of the synapsin I (syn1) gene in the rat brain structures. The experiment was conducted on 48 male Wistar rats, divided into two age groups: young (6–8 months, n=21) and aged (18–24 months, n=27). The methodological approach included assessing anxiety levels in the Open Field test and analyzing spatial memory using the Morris Water Maze and the Barnes Maze. Plasma corticosterone levels were determined via ELISA, while syn1gene expression levels in the brain were analyzed using quantitative real-time RT-PCR. The results demonstrate that aging is accompanied by a significant increase in basal corticosterone levels and a decline in spatial learning efficiency. A key finding of the study is the discovery of an age-dependent inversion of the relationship between anxiety levels and syn1 expression in the ventral hippocampus. In young animals, high syn1 expression was associated with a low-anxiety phenotype, whereas in the aged group, elevated expression of this gene was characteristic of high-anxiety individuals. This suggests a profound functional reorganization of the limbic system during ontogenesis. It was shown that the impact of anxiety on cognitive performance manifests predominantly in old age and depends on the stress intensity of the task context. High anxiety in aged rats correlates with impaired performance in the Morris Water Maze (high-stress model) but facilitates more successful spatial learning in the Barnes Maze (moderate-stress model). Furthermore, the data indicate that corticosterone levels and trait anxiety act as independent predictors: high basal hormone concentrations negatively affect memory retrieval regardless of the animal's age or behavioral phenotype. The findings broaden our understanding of the mechanisms...